IDEAYA Biosciences, Inc.
Developing precision oncology therapies for molecularly defined cancers, led by darovasertib in uveal melanoma.
Precision oncology · Targeted small molecules and ADCs · Registrational Phase 2/3
Developing precision oncology therapies for molecularly defined cancers, led by darovasertib in uveal melanoma.
Precision oncology · Targeted small molecules and ADCs · Registrational Phase 2/3